Investigadores avanzan en el estudio del glioblastoma en el laboratorio utilizando materiales de vanguardia

by Bionand

El estudio muestra cómo modelos 3D de glioblastoma responden a un nanocompuesto activado y analizado con luz de sincrotrón

Read more

Two CRG researchers awarded FERO Cancer grants to advance childhood cancer research and early diagnosis

by Centre for Genomic Regulation

Two researchers from the Centre for Genomic Regulation (CRG) have been recognised in the latest round of the FERO Cancer grants for the pioneering potential of their work to improve the diagnosis and...

Read more

Elisa Espinet receives a FERO grant to investigate the mechanisms of resistance to new therapies against pancreatic cancer

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

The researcher will study how the tumour environment influences the response to Pan-KRAS inhibitors, one of the most promising therapeutic strategies against pancreatic ductal adenocarcinoma.

Read more

La pista escondida en el ARN que podría ayudar a tratar y frenar el cáncer de próstata

by Universidad de Salamanca

La investigación del Centro de Investigación del Cáncer, liderada por Sandra Blanco, explora el potencial del epitranscriptoma para desarrollar nuevos fármacos capaces de mejorar la respuesta a lo...

Read more

ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress

by Oryzon Genomics

In first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels of clinical activity, with 100% (18/18) ORR, 89% (16/18) CRc and 78% (14/18) CR, and continued to demo...

Read more

Anna Bigas co-leads a new project on T-cell Acute Lymphoblastic Leukaemia, funded by the Deutsche José Carreras Leukämie Stiftung

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

The project aims to determine how genetic alterations affecting the BAF complex, and the epigenetic changes they trigger, contribute to treatment resistance and disease progression.

Read more

Anticuerpos frente al C telopéptido de COL11A1: nuevas herramientas para estudiar el remodelado tumoral

by Abyntek

En este artículo se describe un enfoque experimental centrado en el desarrollo de anticuerpos monoclonales dirigidos frente al C‑telopéptido de COL11A1, una región clave pero poco caracterizada. ...

Read more

Cells of a rare lung tumour can reawaken after withdrawal of a specific drug treatment

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

The study reveals that drug-induced senescence, as part of therapeutic strategies against cancer, may not always be definitive. In some tumors, “aged” tumor cells can regrow once the drug is remov...

Read more

Todd Yeates, inventor of ‘protein Lego’, will design nanomolecules with therapeutic potential as a Fundación Occident Visiting Researcher at CNIO

by CNIO - Centro Nacional de Investigaciones Oncológicas

Yeates is the inventor of protein nanoparticles that assemble themselves, much like ‘Lego’ bricks. They are used to visualise very small proteins that are targets for anti-cancer drugs.

Read more

Vall d’Hebron leads a European project to test a new, more effective and less toxic drug against childhood cancer

by Vall d’Hebron

The PHOENIX project, involving 13 European institutions, will evaluate for the first time in paediatric patients the drug ibrilatazar from AbilityPharma in a phase I/II clinical trial.

Read more

Álvarez-Vallina aims to generate STAb-T cells against multiple myeloma directly in the body

by CNIO - Centro Nacional de Investigaciones Oncológicas

The HMarBCN -CNIO Cancer Immunotherapy Clinical Research Unit has just received funding from the Deutsche José Carreras Leukämie Stiftung for a project aimed at modifying T cells directly within the...

Read more

Shilpa Biocare invests in Gate2Brain, an IRB Barcelona spin-off, to advance an innovative therapeutic candidate for brain cancer

by IRB Barcelona - Instituto de Investigación Biomédica

Gate2Brain signs a strategic partnership with Shilpa Biocare, including a €7 million investment for a 30.4% equity stake in the company.

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream